dsm-firmenich has divested its Animal Nutrition & Health business to CVC for an enterprise value of approximately €2.2 billion, retaining a 20% equity stake in the newly formed entities based in Switzerland.

Information on the target

dsm-firmenich has announced the divestment of its Animal Nutrition & Health (ANH) business to CVC for an enterprise value of approximately €2.2 billion, which includes an earnout of up to €0.5 billion. As part of this transaction, dsm-firmenich will retain a 20% equity stake in the newly formed ANH Companies, which will operate as two standalone entities based in Kaiseraugst, Switzerland. This strategic move follows the prior sale of the Feed Enzymes activities for €1.5 billion in 2025, marking a significant step in dsm-firmenich's transition to a consumer-focused company in the nutrition, health, and beauty sectors.

The ANH business is recognized globally for its science-based solutions in animal nutrition and health, providing a wide range of products that enhance animal health, performance, and sustainability in livestock production. With annualized net sales of approximately €3.5 billion in 2025 and a workforce of around 8,000 employees, the divestment encompasses all ANH activities, including Performance Solutions, Premix, Precision Services, and Vitamins, Carotenoids, and Aroma Ingredients.

Industry overview in the target’s specific country

Switzerland, known for its robust agricultural sector, plays a pivotal role in the global animal nutrition and health industry. The country is home to a number of leading companies and research institutions that focus on innovative solutions to enhance li